Healthcare & Life Sciences

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.

“We’re building a world where doctors spend more time looking their patients in the eye,” says Lucy Orr-Ewing, Head of Policy at the Coalition for Health AI.

How are companies deploying AI to advance sustainability priorities and create social value?

As a practical matter, long-term success demands ESG discipline, says Dr. Jeane Tsutsui, CEO of Brazilian medical diagnostics company Grupo Fleury. She speaks with Brunswick’s Roberta Lippi and Daniel Wiedemann about her journey.

From “green” chemicals to carbon-neutral cement, the power of microbes to make industrial materials could play a key role in the transition away from fossil fuels. Brunswick’s Ben Hirschler reports.

As a child in Gloucestershire, England in the 1760s, Edward Jenner, creator of the first widely used vaccine, overheard a dairy maid say, “I shall never have smallpox because I have had cowpox. I shall…

A new hospital brings to the UK both state-of-the-art technology and a distinctive approach to care. Brunswick’s Aideen Lee and Kathleen Lang report.

GE HealthCare’s outgoing president and CEO for China, Yihao Zhang, reflects on the components of success in the country’s increasingly competitive market.

AI will have—and is already having—a major impact on global challenges. Here’s our perspective on the implications for business across 9 key societal issues. By Jon Miller.

Will Bateman, CEO of CCell, speaks with Brunswick’s Alex Burnett and Jack Stewart.

OneTeam Partners is delivering financial justice to third-string linemen, female players and other undervalued competitors across a growing number of professional and college sports.

Brunswick Contracts and Data Manager Graham Carter recalls his late wife's courage.